Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-75,278
Closed -$1.43M 5511
2026
Q1
$1.43M Buy
75,278
+10,399
+16% +$201K ﹤0.01% 1828
2025
Q4
$1.06M Sell
64,879
-366,843
-85% -$6.46M ﹤0.01% 1675
2025
Q3
$8.11M Sell
431,722
-239,119
-36% -$4.29M 0.03% 463
2025
Q2
$13.6M Buy
670,841
+127,771
+24% +$2.21M 0.06% 233
2025
Q1
$7.47M Buy
543,070
+251,023
+86% +$3.46M 0.05% 303
2024
Q4
$3.46M Buy
+292,047
New +$4.6M 0.02% 530
2024
Q3
Sell
-424,713
Closed -$7.47M 3248
2024
Q2
$7.47M Sell
424,713
-210,500
-33% -$4.35M 0.04% 292
2024
Q1
$16.3M Sell
635,213
-626,971
-50% -$15.7M 0.1% 96
2023
Q4
$32.9M Buy
+1,262,184
New +$28.8M 0.24% 38
2022
Q2
Sell
-22,745
Closed -$684K 3857
2022
Q1
$684K Buy
+22,745
New +$709K ﹤0.01% 1407

Other funds holding XP

HRT Financial's XP Position: Q2 2026 in Review

HRT Financial sold out of XP (XP) in Q2 2026, closing a stake of 75,278 shares — an estimated $1.43M sold.

HRT Financial first reported a position in XP in Q1 2022 and held it in 10 quarters. The position peaked at $32.9M in Q4 2023. 321 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • HRT Financial reported no remaining XP position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 75,278 XP shares in Q2 2026, an estimated $1.43M.
  • HRT Financial first reported a position in XP in Q1 2022 and held it in 10 quarters.
  • HRT Financial's XP position peaked at $32.9M in Q4 2023.
  • 321 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.